[{"id":"08544267-425c-42aa-87ee-a72f61d133e8","acronym":"","url":"https://clinicaltrials.gov/study/NCT04614740","created_at":"2021-02-22T08:58:34.782Z","updated_at":"2024-07-02T16:35:59.178Z","phase":"Phase 2","brief_title":"The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors","source_id_and_acronym":"NCT04614740","lead_sponsor":"Jiangsu vcare pharmaceutical technology co., LTD","biomarkers":" NTRK","pipe":" | ","alterations":" NTRK positive • NTRK fusion","tags":["NTRK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NTRK positive • NTRK fusion"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e VC004"],"overall_status":"Recruiting","enrollment":" Enrollment 115","initiation":"Initiation: 11/20/2020","start_date":" 11/20/2020","primary_txt":" Primary completion: 01/31/2024","primary_completion_date":" 01/31/2024","study_txt":" Completion: 06/30/2024","study_completion_date":" 06/30/2024","last_update_posted":"2022-12-13"}]